T-bet Activates Th1 Genes through Mediator and the Super Elongation Complex

Cell Reports

Volumn 15, Issue 12, 2016, Pages 2756-2770

  Hertweck, Arnulf ^a,b   Evans, Catherine M ^a   Eskandarpour, Malihe ^c   Lau, Jonathan C H ^a   Oleinika, Kristine ^a   Jackson, Ian ^b   Kelly, Audrey ^d   Ambrose, John ^a   Adamson, Peter ^c   Cousins, David J ^d,e   Lavender, Paul ^d   Calder, Virginia L ^c   Lord, Graham M ^b   Jenner, Richard G ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b GUY'S AND ST THOMAS' NHS FOUNDATION TRUST   (United Kingdom)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

^d KING'S COLLEGE LONDON   (United Kingdom)

^e UNIVERSITY OF LEICESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

4 (4 CHLOROPHENYL) 2,3,9 TRIMETHYL 6H THIENO[3,2 F][1,2,4]TRIAZOLO[4,3 A][1,4]DIAZEPINE 6 ACETIC ACID TERT BUTYL ESTER; FLAVOPIRIDOL; HISTONE H3; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MEDIATOR COMPLEX; POSITIVE TRANSCRIPTION ELONGATION FACTOR B; PROTEIN BRD4; RNA POLYMERASE II; SUPER ELONGATION COMPLEX; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR RELA; TRANSCRIPTION FACTOR T BET; UNCLASSIFIED DRUG; BRD4 PROTEIN, MOUSE; NUCLEAR PROTEIN; PROTEIN BINDING; RNA; T BOX TRANSCRIPTION FACTOR; T-BOX TRANSCRIPTION FACTOR TBX21;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOIMMUNE UVEITIS; CELL FATE; CELL LINEAGE; CONTROLLED STUDY; ENHANCER REGION; GENE ACTIVATION; GENE EXPRESSION; GENE SILENCING; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; TH1 CELL; TH2 CELL; TRANSCRIPTION ELONGATION; TRANSCRIPTION INITIATION; ANIMAL; C57BL MOUSE; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; UVEITIS;

ANIMALS; CELL LINEAGE; ENHANCER ELEMENTS, GENETIC; GENE EXPRESSION REGULATION; HUMANS; MICE, INBRED C57BL; NUCLEAR PROTEINS; POSITIVE TRANSCRIPTIONAL ELONGATION FACTOR B; PROTEIN BINDING; RNA; T-BOX DOMAIN PROTEINS; TH1 CELLS; TH2 CELLS; TRANSCRIPTION ELONGATION, GENETIC; TRANSCRIPTION FACTOR RELA; TRANSCRIPTION FACTORS; UVEITIS;

EID: 84975154592     PISSN: None     EISSN: 22111247     Source Type: Journal    
DOI: 10.1016/j.celrep.2016.05.054     Document Type: Article

References (53)

1. Agarwal R.K., Silver P.B., Caspi R.R. Rodent models of experimental autoimmune uveitis. Methods Mol. Biol. 2012, 900:443-469.
2. Balasubramani A., Shibata Y., Crawford G.E., Baldwin A.S., Hatton R.D., Weaver C.T. Modular utilization of distal cis-regulatory elements controls Ifng gene expression in T cells activated by distinct stimuli. Immunity 2010, 33:35-47.
3. Bandukwala H.S., Gagnon J., Togher S., Greenbaum J.A., Lamperti E.D., Parr N.J., Molesworth A.M., Smithers N., Lee K., Witherington J., et al. Selective inhibition of CD4+ T-cell cytokine production and autoimmunity by BET protein and c-Myc inhibitors. Proc. Natl. Acad. Sci. USA 2012, 109:14532-14537.
4. Barboric M., Nissen R.M., Kanazawa S., Jabrane-Ferrat N., Peterlin B.M. NF-kappaB binds P-TEFb to stimulate transcriptional elongation by RNA polymerase II. Mol. Cell 2001, 8:327-337.
5. Brown J.D., Lin C.Y., Duan Q., Griffin G., Federation A.J., Paranal R.M., Bair S., Newton G., Lichtman A.H., Kung A.L., et al. NF-κB directs dynamic super enhancer formation in inflammation and atherogenesis. Mol. Cell 2014, 56:219-231.
6. Carlsten J.O., Zhu X., Gustafsson C.M. The multitalented Mediator complex. Trends Biochem. Sci. 2013, 38:531-537.
7. Chapuy B., McKeown M.R., Lin C.Y., Monti S., Roemer M.G., Qi J., Rahl P.B., Sun H.H., Yeda K.T., Doench J.G., et al. Discovery and characterization of super-enhancer-associated dependencies in diffuse large B cell lymphoma. Cancer Cell 2013, 24:777-790.
8. Di Micco R., Fontanals-Cirera B., Low V., Ntziachristos P., Yuen S.K., Lovell C.D., Dolgalev I., Yonekubo Y., Zhang G., Rusinova E., et al. Control of embryonic stem cell identity by BRD4-dependent transcriptional elongation of super-enhancer-associated pluripotency genes. Cell Rep. 2014, 9:234-247.
9. Donner A.J., Ebmeier C.C., Taatjes D.J., Espinosa J.M. CDK8 is a positive regulator of transcriptional elongation within the serum response network. Nat. Struct. Mol. Biol. 2010, 17:194-201.
10. Gardner P.J., Joshi L., Lee R.W., Dick A.D., Adamson P., Calder V.L. SIRT1 activation protects against autoimmune T cell-driven retinal disease in mice via inhibition of IL-2/Stat5 signaling. J. Autoimmun. 2013, 42:117-129.
11. Hatton R.D., Harrington L.E., Luther R.J., Wakefield T., Janowski K.M., Oliver J.R., Lallone R.L., Murphy K.M., Weaver C.T. A distal conserved sequence element controls Ifng gene expression by T cells and NK cells. Immunity 2006, 25:717-729.
12. Hawkins R.D., Larjo A., Tripathi S.K., Wagner U., Luu Y., Lönnberg T., Raghav S.K., Lee L.K., Lund R., Ren B., et al. Global chromatin state analysis reveals lineage-specific enhancers during the initiation of human T helper 1 and T helper 2 cell polarization. Immunity 2013, 38:1271-1284.
13. Hnisz D., Abraham B.J., Lee T.I., Lau A., Saint-André V., Sigova A.A., Hoke H.A., Young R.A. Super-enhancers in the control of cell identity and disease. Cell 2013, 155:934-947.
14. Huang B., Yang X.D., Zhou M.M., Ozato K., Chen L.F. Brd4 coactivates transcriptional activation of NF-kappaB via specific binding to acetylated RelA. Mol. Cell. Biol. 2009, 29:1375-1387.
15. Hwang E.S., Hong J.H., Glimcher L.H. IL-2 production in developing Th1 cells is regulated by heterodimerization of RelA and T-bet and requires T-bet serine residue 508. J. Exp. Med. 2005, 202:1289-1300.
16. Jang M.K., Mochizuki K., Zhou M., Jeong H.S., Brady J.N., Ozato K. The bromodomain protein Brd4 is a positive regulatory component of P-TEFb and stimulates RNA polymerase II-dependent transcription. Mol. Cell 2005, 19:523-534.
17. Kanhere A., Hertweck A., Bhatia U., Gökmen M.R., Perucha E., Jackson I., Lord G.M., Jenner R.G. T-bet and GATA3 orchestrate Th1 and Th2 differentiation through lineage-specific targeting of distal regulatory elements. Nat. Commun. 2012, 3:1268.
18. Koch F., Fenouil R., Gut M., Cauchy P., Albert T.K., Zacarias-Cabeza J., Spicuglia S., de la Chapelle A.L., Heidemann M., Hintermair C., et al. Transcription initiation platforms and GTF recruitment at tissue-specific enhancers and promoters. Nat. Struct. Mol. Biol. 2011, 18:956-963.
19. Lam M.T., Li W., Rosenfeld M.G., Glass C.K. Enhancer RNAs and regulated transcriptional programs. Trends Biochem. Sci. 2014, 39:170-182.
20. Lazarevic V., Glimcher L.H., Lord G.M. T-bet: a bridge between innate and adaptive immunity. Nat. Rev. Immunol. 2013, 13:777-789.
21. Lin C., Garruss A.S., Luo Z., Guo F., Shilatifard A. The RNA Pol II elongation factor Ell3 marks enhancers in ES cells and primes future gene activation. Cell 2013, 152:144-156.
22. Lovén J., Hoke H.A., Lin C.Y., Lau A., Orlando D.A., Vakoc C.R., Bradner J.E., Lee T.I., Young R.A. Selective inhibition of tumor oncogenes by disruption of super-enhancers. Cell 2013, 153:320-334.
23. Mele D.A., Salmeron A., Ghosh S., Huang H.R., Bryant B.M., Lora J.M. BET bromodomain inhibition suppresses TH17-mediated pathology. J. Exp. Med. 2013, 210:2181-2190.
24. Messi M., Giacchetto I., Nagata K., Lanzavecchia A., Natoli G., Sallusto F. Memory and flexibility of cytokine gene expression as separable properties of human T(H)1 and T(H)2 lymphocytes. Nat. Immunol. 2003, 4:78-86.
25. Miller S.A., Huang A.C., Miazgowicz M.M., Brassil M.M., Weinmann A.S. Coordinated but physically separable interaction with H3K27-demethylase and H3K4-methyltransferase activities are required for T-box protein-mediated activation of developmental gene expression. Genes Dev. 2008, 22:2980-2993.
26. Murphy K.M., Stockinger B. Effector T cell plasticity: flexibility in the face of changing circumstances. Nat. Immunol. 2010, 11:674-680.
27. Nakayamada S., Kanno Y., Takahashi H., Jankovic D., Lu K.T., Johnson T.A., Sun H.W., Vahedi G., Hakim O., Handon R., et al. Early Th1 cell differentiation is marked by a Tfh cell-like transition. Immunity 2011, 35:919-931.
28. Natoli G., Andrau J.C. Noncoding transcription at enhancers: general principles and functional models. Annu. Rev. Genet. 2012, 46:1-19.
29. Nicodeme E., Jeffrey K.L., Schaefer U., Beinke S., Dewell S., Chung C.W., Chandwani R., Marazzi I., Wilson P., Coste H., et al. Suppression of inflammation by a synthetic histone mimic. Nature 2010, 468:1119-1123.
30. O'Shea J.J., Paul W.E. Mechanisms underlying lineage commitment and plasticity of helper CD4+ T cells. Science 2010, 327:1098-1102.
31. Parker S.C., Stitzel M.L., Taylor D.L., Orozco J.M., Erdos M.R., Akiyama J.A., van Bueren K.L., Chines P.S., Narisu N., Black B.L., et al. Chromatin stretch enhancer states drive cell-specific gene regulation and harbor human disease risk variants. Proc. Natl. Acad. Sci. USA 2013, 110:17921-17926.
32. Peeters J.G., Vervoort S.J., Tan S.C., Mijnheer G., de Roock S., Vastert S.J., Nieuwenhuis E.E., van Wijk F., Prakken B.J., Creyghton M.P., et al. Inhibition of super-enhancer activity in autoinflammatory site-derived T cells reduces disease-associated gene expression. Cell Rep. 2015, 12:1986-1996.
33. Schoenborn J.R., Dorschner M.O., Sekimata M., Santer D.M., Shnyreva M., Fitzpatrick D.R., Stamatoyannopoulos J.A., Wilson C.B. Comprehensive epigenetic profiling identifies multiple distal regulatory elements directing transcription of the gene encoding interferon-gamma. Nat. Immunol. 2007, 8:732-742.
34. Sharma M., George A.A., Singh B.N., Sahoo N.C., Rao K.V. Regulation of transcript elongation through cooperative and ordered recruitment of cofactors. J. Biol. Chem. 2007, 282:20887-20896.
35. Shnyreva M., Weaver W.M., Blanchette M., Taylor S.L., Tompa M., Fitzpatrick D.R., Wilson C.B. Evolutionarily conserved sequence elements that positively regulate IFN-gamma expression in T cells. Proc. Natl. Acad. Sci. USA 2004, 101:12622-12627.
36. Sica A., Dorman L., Viggiano V., Cippitelli M., Ghosh P., Rice N., Young H.A. Interaction of NF-kappaB and NFAT with the interferon-gamma promoter. J. Biol. Chem. 1997, 272:30412-30420.
37. Smith E., Shilatifard A. Enhancer biology and enhanceropathies. Nat. Struct. Mol. Biol. 2014, 21:210-219.
38. Spitz F., Furlong E.E. Transcription factors: from enhancer binding to developmental control. Nat. Rev. Genet. 2012, 13:613-626.
39. Stubbington M.J., Mahata B., Svensson V., Deonarine A., Nissen J.K., Betz A.G., Teichmann S.A. An atlas of mouse CD4(+) T cell transcriptomes. Biol. Direct 2015, 10:14.
40. Szabo S.J., Kim S.T., Costa G.L., Zhang X., Fathman C.G., Glimcher L.H. A novel transcription factor, T-bet, directs Th1 lineage commitment. Cell 2000, 100:655-669.
41. Takahashi H., Parmely T.J., Sato S., Tomomori-Sato C., Banks C.A., Kong S.E., Szutorisz H., Swanson S.K., Martin-Brown S., Washburn M.P., et al. Human mediator subunit MED26 functions as a docking site for transcription elongation factors. Cell 2011, 146:92-104.
42. Vahedi G., Takahashi H., Nakayamada S., Sun H.W., Sartorelli V., Kanno Y., O'Shea J.J. STATs shape the active enhancer landscape of T cell populations. Cell 2012, 151:981-993.
43. Vahedi G., Kanno Y., Furumoto Y., Jiang K., Parker S.C., Erdos M.R., Davis S.R., Roychoudhuri R., Restifo N.P., Gadina M., et al. Super-enhancers delineate disease-associated regulatory nodes in T cells. Nature 2015, 520:558-562.
44. van Essen D., Engist B., Natoli G., Saccani S. Two modes of transcriptional activation at native promoters by NF-kappaB p65. PLoS Biol. 2009, 7:e73.
45. Wang W., Yao X., Huang Y., Hu X., Liu R., Hou D., Chen R., Wang G. Mediator MED23 regulates basal transcription in vivo via an interaction with P-TEFb. Transcription 2013, 4:39-51.
46. Wei G., Wei L., Zhu J., Zang C., Hu-Li J., Yao Z., Cui K., Kanno Y., Roh T.Y., Watford W.T., et al. Global mapping of H3K4me3 and H3K27me3 reveals specificity and plasticity in lineage fate determination of differentiating CD4+ T cells. Immunity 2009, 30:155-167.
47. Wei G., Abraham B.J., Yagi R., Jothi R., Cui K., Sharma S., Narlikar L., Northrup D.L., Tang Q., Paul W.E., et al. Genome-wide analyses of transcription factor GATA3-mediated gene regulation in distinct T cell types. Immunity 2011, 35:299-311.
48. Whyte W.A., Orlando D.A., Hnisz D., Abraham B.J., Lin C.Y., Kagey M.H., Rahl P.B., Lee T.I., Young R.A. Master transcription factors and mediator establish super-enhancers at key cell identity genes. Cell 2013, 153:307-319.
49. Wienerroither S., Shukla P., Farlik M., Majoros A., Stych B., Vogl C., Cheon H., Stark G.R., Strobl B., Müller M., Decker T. Cooperative transcriptional activation of antimicrobial genes by STAT and NF-κB pathways by concerted recruitment of the Mediator complex. Cell Rep. 2015, 12:300-312.
50. Yang Z., Yik J.H., Chen R., He N., Jang M.K., Ozato K., Zhou Q. Recruitment of P-TEFb for stimulation of transcriptional elongation by the bromodomain protein Brd4. Mol. Cell 2005, 19:535-545.
51. Zhang W., Prakash C., Sum C., Gong Y., Li Y., Kwok J.J., Thiessen N., Pettersson S., Jones S.J., Knapp S., et al. Bromodomain-containing protein 4 (BRD4) regulates RNA polymerase II serine 2 phosphorylation in human CD4+ T cells. J. Biol. Chem. 2012, 287:43137-43155.
52. *). Annu. Rev. Immunol. 2010, 28:445-489.
53. Zhu J., Jankovic D., Oler A.J., Wei G., Sharma S., Hu G., Guo L., Yagi R., Yamane H., Punkosdy G., et al. The transcription factor T-bet is induced by multiple pathways and prevents an endogenous Th2 cell program during Th1 cell responses. Immunity 2012, 37:660-673.